Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

For the study, the investigators randomised people at high risk of asthma or COPD attack into three groups, one receiving benralizumab injection and dummy tablets, one receiving standard of care ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used for the treatment of severe asthma.